Barclays plans to price autocallable securities linked to Regeneron

By Wendy Van Sickle

Columbus, Ohio, Sept. 28 – Barclays Bank plc plans to price 0% autocallable securities due Oct. 3, 2019 linked to the common stock of Regeneron Pharmaceuticals, Inc., according to an FWP filing with the Securities and Exchange Commission.

The notes will be called quarterly at par of $10 plus a premium of 11.25% a year if the shares close at or above 95% of their initial level on the determination date for that quarter.

The payout at maturity will be par plus 33.75% if the shares finish above the 95% redemption threshold;if the shares close below the redemption threshold but above the 85% trigger value, the payout will be par; otherwise, investors will be fully exposed to the decline in the share price.

Barclays is the agent. Morgan Stanley Wealth Management is a dealer.

The notes will price on Sept. 30 and settle on Oct. 5.

The Cusip number is 06745B235.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.